US Stock MarketDetailed Quotes

ADVM Adverum Biotechnologies

Watchlist
  • 6.0400
  • +0.2900+5.04%
Close Nov 22 16:00 ET
  • 6.0400
  • 0.00000.00%
Post 20:01 ET
125.65MMarket Cap-1015P/E (TTM)

Adverum Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adverum Biotechnologies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q31.000M / 62.500K--
--2024/Q20.000 / 66.250K--
--2024/Q10.000 / 72.860K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q31.000M / 62.500K--
--2024/Q20.000 / 66.250K--
--2024/Q10.000 / 72.860K--

Unlock Free Earnings Estimates

Adverum Biotechnologies Earnings Reports

  • Adverum Biotechnologies | 10-Q: Q3 2024 Earnings Report

    Nov 4 16:50 ET

  • Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones

    Nov 4 16:45 ET

  • Adverum Biotechnologies | 10-Q: Q2 2024 Earnings Report

    Aug 12 16:18 ET

  • Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights

    Aug 12 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 22, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data